Timothy Piser

Title: The Innovative Contributions of Timothy Piser

Introduction

Timothy Piser is a notable inventor based in Wilmington, Delaware. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target neurological and psychiatric disorders. With a total of seven patents to his name, Piser's work has the potential to impact the treatment of various diseases affecting the nervous system.

Latest Patents

Among his latest patents, Piser has developed heteroaromatic NMDA receptor modulators. These include a specific compound, 5-(3-chloro-4-fluorophenyl)-7-cyclopropyl-3-(2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl)-3,7-dihydro-4H-pyrrolo[2,3-d]pyrimidin-4-one, along with its pharmaceutically acceptable salts. These compounds are designed for use in treating psychiatric, neurological, and neurodevelopmental disorders, as well as various diseases of the nervous system.

Career Highlights

Piser has worked with prominent companies in the pharmaceutical industry, including AstraZeneca and Cadent Therapeutics, Inc. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research and development in the field.

Collaborations

Throughout his career, Piser has collaborated with esteemed colleagues such as David R. Anderson and Robert A. Volkmann. These partnerships have fostered an environment of innovation and have led to the advancement of important therapeutic solutions.

Conclusion

Timothy Piser's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his commitment to improving treatments for neurological and psychiatric disorders. His work continues to pave the way for advancements in medical science.